An analysis of pharmaceutical experience with decades of rat carcinogenicity testing: support for a proposal to modify current regulatory guidelines.
作者:
主题词
动物(Animals);致癌性试验(Carcinogenicity Tests);致癌物(Carcinogens);数据库, 事实型(Databases, Factual);决策树(Decision Trees);疾病模型, 动物(Disease Models, Animal);评价研究(主题)(Evaluation Studies as Topic);女(雌)性(Female);指导方针(主题)(Guidelines as Topic);人类(Humans);免疫抑制剂(Immunosuppressive Agents);男(雄)性(Male);小鼠(Mice);小鼠, 转基因(Mice, Transgenic);诱变力试验(Mutagenicity Tests);肿瘤(Neoplasms);大鼠(Rats);大鼠, 近交F344(Rats, Inbred F344);危险因素(Risk Factors);统计学(主题)(Statistics as Topic);毒性试验, 慢性(Toxicity Tests, Chronic)
DOI
10.1177/0192623311406935
PMID
21666103
发布时间
2011-11-08
- 浏览36

Toxicologic pathology
716-44页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文